syndrome	score	normalized_score
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.509112471	100.0
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.500915751	98.38999818961418
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.500915751	98.38999818961418
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.5	98.2101261471554
CULLER-JONES SYNDROME; CJS	0.3333333	65.4734108840952
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.250915751	49.28493511603648
HYPERLIPOPROTEINEMIA, TYPE IV	0.25	49.1050630735777
HYPERTRIGLYCERIDEMIA, FAMILIAL	0.25	49.1050630735777
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.200915751	39.46392250132093
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.200915751	39.46392250132093
VICI SYNDROME; VICIS	0.200915751	39.46392250132093
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.2	39.28405045886216
SCHIZENCEPHALY	0.2	39.28405045886216
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.14377275099999998	28.239880024467123
PALLISTER-HALL SYNDROME	0.14377275099999998	28.239880024467123
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.14377275099999998	28.239880024467123
HOLOPROSENCEPHALY 7	0.14377275099999998	28.239880024467123
PANHYPOPITUITARISM, X-LINKED	0.14285699999999998	28.060007982008354
JOUBERT SYNDROME 26	0.14285699999999998	28.060007982008354
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.14285699999999998	28.060007982008354
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.134112471	26.342405389633445
CHROMOSOME 1P36 DELETION SYNDROME	0.13411247099999998	26.342405389633438
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.125915751	24.732403579247617
TUBEROUS SCLEROSIS	0.125915751	24.732403579247617
TUBEROUS SCLEROSIS 2; TSC2	0.125915751	24.732403579247617
EXUDATIVE VITREORETINOPATHY 5; EVR5	0.125	24.55253153678885
AICARDI SYNDROME; AIC	0.125	24.55253153678885
EXUDATIVE VITREORETINOPATHY 4	0.125	24.55253153678885
#133780 EXUDATIVE VITREORETINOPATHY 1; EVR1;;EXUDATIVE VITREORETINOPATHY, FAMILIAL, AUTOSOMAL DOMINANT;;FEVR, AUTOSOMAL DOMINANT;;CRISWICK-SCHEPENS SYNDROMERETINOPATHY OF PREMATURITY, INCLUDED; ROP, INCLUDED	0.125	24.55253153678885
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.125	24.55253153678885
EXUDATIVE VITREORETINOPATHY 3; EVR3	0.125	24.55253153678885
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.125	24.55253153678885
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.125	24.55253153678885
#305390 EXUDATIVE VITREORETINOPATHY 2, X-LINKED; EVR2;;EXUDATIVE VITREORETINOPATHY, FAMILIAL, 2;;EVRX;;FEVR, X-LINKED; FEVRX	0.125	24.55253153678885
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.125	24.55253153678885
#143200 WAGNER VITREORETINOPATHY; WGVRP;;EROSIVE VITREORETINOPATHY; ERVR;;WAGNER VITREORETINAL DEGENERATION;;HYALOIDEORETINAL DEGENERATION OF WAGNER;;WAGNER SYNDROME 1; WGN1	0.125	24.55253153678885
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.10465725100000002	20.556803645849016
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.09244577100000002	18.158221663362088
HOLOPROSENCEPHALY 2; HPE2	0.09244577100000002	18.158221663362088
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.08424905100000002	16.548219852976263
WEBB-DATTANI SYNDROME; WEDAS	0.08424905100000002	16.548219852976263
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.08424905100000002	16.548219852976263
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.08424905100000002	16.548219852976263
HOLOPROSENCEPHALY 1; HPE1	0.08424905100000002	16.548219852976263
SEPTOOPTIC DYSPLASIA	0.08333330000000001	16.368347810517495
HARTSFIELD SYNDROME; HRTFDS	0.08333330000000001	16.368347810517495
ALSTROM SYNDROME; ALMS	0.08333330000000001	16.368347810517495
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.029520671	5.7984576457173445
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.029520671	5.7984576457173445
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.029520671	5.7984576457173445
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.029520671	5.7984576457173445
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.029520671	5.7984576457173445
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.02860492	5.618585603258578
INFANTILE SIALIC ACID STORAGE DISEASE	0.021323950999999997	4.188455835331521
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.021323950999999997	4.188455835331521
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.021323950999999997	4.188455835331521
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.021323950999999997	4.188455835331521
KAGAMI-OGATA SYNDROME	0.021323950999999997	4.188455835331521
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.021323950999999997	4.188455835331521
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.021323950999999997	4.188455835331521
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.021323950999999997	4.188455835331521
GAUCHER DISEASE, PERINATAL LETHAL	0.021323950999999997	4.188455835331521
YUNIS-VARON SYNDROME	0.020408199999999998	4.008583792872754
RESTRICTIVE DERMOPATHY, LETHAL	0.020408199999999998	4.008583792872754
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.020408199999999998	4.008583792872754
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.020408199999999998	4.008583792872754
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.020408199999999998	4.008583792872754
Diamond-Blackfan anemia 1	0.020408199999999998	4.008583792872754
ROIFMAN SYNDROME; RFMN	0.020408199999999998	4.008583792872754
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.020408199999999998	4.008583792872754
#267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS;;RDS OF PREMATURITY;;HYALINE MEMBRANE DISEASE, FORMERLY	0.020408199999999998	4.008583792872754
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.020408199999999998	4.008583792872754
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.020408199999999998	4.008583792872754
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.020408199999999998	4.008583792872754
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.020408199999999998	4.008583792872754
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.020408199999999998	4.008583792872754
NEMALINE MYOPATHY 10	0.020408199999999998	4.008583792872754
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.020408199999999998	4.008583792872754
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.020408199999999998	4.008583792872754
COSTELLO SYNDROME; CSTLO	0.020408199999999998	4.008583792872754
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.020408199999999998	4.008583792872754
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.020408199999999998	4.008583792872754
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.020408199999999998	4.008583792872754
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.020408199999999998	4.008583792872754
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.020408199999999998	4.008583792872754
ATELOSTEOGENESIS, TYPE I; AO1	0.020408199999999998	4.008583792872754
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.020408199999999998	4.008583792872754
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.020408199999999998	4.008583792872754
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.020408199999999998	4.008583792872754
TEMPLE SYNDROME	0.020408199999999998	4.008583792872754
#242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'	0.020408199999999998	4.008583792872754
TYSHCHENKO SYNDROME	0.020408199999999998	4.008583792872754
KNIEST-LIKE DYSPLASIA, LETHAL	0.020408199999999998	4.008583792872754
CORNEODERMATOOSSEOUS SYNDROME	0.020408199999999998	4.008583792872754
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.020408199999999998	4.008583792872754
RETT SYNDROME; RTT	0.009112470999999999	1.7898738528445906
SCHAAF-YANG SYNDROME; SHFYNG	0.009112470999999999	1.7898738528445906
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.009112470999999999	1.7898738528445906
GITELMAN SYNDROME	0.009112470999999999	1.7898738528445906
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.009112470999999999	1.7898738528445906
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.009112470999999999	1.7898738528445906
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.009112470999999999	1.7898738528445906
SMITH-MAGENIS SYNDROME; SMS	0.009112470999999999	1.7898738528445906
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.009112470999999999	1.7898738528445906
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.009112470999999999	1.7898738528445906
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.009112470999999999	1.7898738528445906
DESANTO-SHINAWI SYNDROME	0.009112470999999999	1.7898738528445906
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.009112470999999999	1.7898738528445906
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.009112470999999999	1.7898738528445906
PROPIONIC ACIDEMIA	0.009112470999999999	1.7898738528445906
611961 STEVENSON-CAREY SYNDROME	0.009112470999999999	1.7898738528445906
ANGELMAN SYNDROME	0.009112470999999999	1.7898738528445906
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.009112470999999999	1.7898738528445906
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.009112470999999999	1.7898738528445906
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.009112470999999999	1.7898738528445906
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.009112470999999999	1.7898738528445906
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.009112470999999999	1.7898738528445906
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.009112470999999999	1.7898738528445906
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.009112470999999999	1.7898738528445906
WIEDEMANN-STEINER SYNDROME; WDSTS	0.009112470999999999	1.7898738528445906
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.009112470999999999	1.7898738528445906
HYPOPHOSPHATASIA, INFANTILE	0.009112470999999999	1.7898738528445906
CHROMOSOME 19p13.13 DELETION SYNDROME	0.009112470999999999	1.7898738528445906
MOWAT-WILSON SYNDROME; MOWS	0.009112470999999999	1.7898738528445906
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.009112470999999999	1.7898738528445906
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.009112470999999999	1.7898738528445906
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.009112470999999999	1.7898738528445906
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.009112470999999999	1.7898738528445906
RETT SYNDROME, CONGENITAL VARIANT	0.009112470999999999	1.7898738528445906
EMANUEL SYNDROME	0.009112470999999999	1.7898738528445906
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.009112470999999999	1.7898738528445906
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.009112470999999999	1.7898738528445906
AUTISM, SUSCEPTIBILITY TO, 18	0.009112470999999999	1.7898738528445906
Xq28 (MECP2) duplication	0.009112470999999999	1.7898738528445906
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.009112470999999999	1.7898738528445906
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.009112470999999999	1.7898738528445906
KAPUR-TORIELLO SYNDROME	0.009112470999999999	1.7898738528445906
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.009112470999999999	1.7898738528445906
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.009112470999999999	1.7898738528445906
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.009112470999999999	1.7898738528445906
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.009112470999999999	1.7898738528445906
PITT-HOPKINS SYNDROME	0.009112470999999999	1.7898738528445906
Glycosylphosphatidylinositol biosynthesis defect 18	0.009112470999999999	1.7898738528445906
LOWE OCULOCEREBRORENAL SYNDROME	0.009112470999999999	1.7898738528445906
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.009112470999999999	1.7898738528445906
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.009112470999999999	1.7898738528445906
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.009112470999999999	1.7898738528445906
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.009112470999999999	1.7898738528445906
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.009112470999999999	1.7898738528445906
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.00819672	1.6100018103858231
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00819672	1.6100018103858231
#606764 GASTROINTESTINAL STROMAL TUMOR; GIST	0.00819672	1.6100018103858231
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.00819672	1.6100018103858231
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00819672	1.6100018103858231
UROFACIAL SYNDROME 2	0.00819672	1.6100018103858231
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00819672	1.6100018103858231
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.00819672	1.6100018103858231
NIEMANN-PICK DISEASE, TYPE A	0.00819672	1.6100018103858231
COFFIN-SIRIS SYNDROME 7; CSS7	0.00819672	1.6100018103858231
#226600 EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB;;DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE; EBR1EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATAVARIANT, INCLUDED;;EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE, INCLUDED	0.00819672	1.6100018103858231
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.00819672	1.6100018103858231
AU-KLINE SYNDROME; AUKS	0.00819672	1.6100018103858231
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.00819672	1.6100018103858231
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00819672	1.6100018103858231
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00819672	1.6100018103858231
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.00819672	1.6100018103858231
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.00819672	1.6100018103858231
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00819672	1.6100018103858231
#308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS;;LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;;ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;;CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	0.00819672	1.6100018103858231
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00819672	1.6100018103858231
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.00819672	1.6100018103858231
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.00819672	1.6100018103858231
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00819672	1.6100018103858231
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00819672	1.6100018103858231
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.00819672	1.6100018103858231
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00819672	1.6100018103858231
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.00819672	1.6100018103858231
VISCERAL MYOPATHY; VSCM	0.00819672	1.6100018103858231
UROFACIAL SYNDROME	0.00819672	1.6100018103858231
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00819672	1.6100018103858231
MYXEDEMA	0.00819672	1.6100018103858231
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00819672	1.6100018103858231
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00819672	1.6100018103858231
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00819672	1.6100018103858231
ERYTHERMALGIA, PRIMARY	0.00819672	1.6100018103858231
300270 ADRENOMYODYSTROPHY	0.00819672	1.6100018103858231
PARKINSON DISEASE, LATE-ONSET; PD	0.00819672	1.6100018103858231
ANAL SPHINCTER DYSPLASIA; ASDP	0.00819672	1.6100018103858231
PORPHYRIA VARIEGATA	0.00819672	1.6100018103858231
FG SYNDROME 2; FGS2	0.00819672	1.6100018103858231
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00819672	1.6100018103858231
WHITE-SUTTON SYNDROME; WHSUS	0.00819672	1.6100018103858231
WILLIAMS-BEUREN SYNDROME; WBS	0.00819672	1.6100018103858231
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00819672	1.6100018103858231
#600072 FATAL FAMILIAL INSOMNIA; FFI;;INSOMNIA, FATAL FAMILIAL	0.00819672	1.6100018103858231
ADIPOSIS DOLOROSA	0.00819672	1.6100018103858231
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00819672	1.6100018103858231
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.00819672	1.6100018103858231
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.00819672	1.6100018103858231
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00819672	1.6100018103858231
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00819672	1.6100018103858231
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00819672	1.6100018103858231
COFFIN-SIRIS SYNDROME 6; CSS6	0.00819672	1.6100018103858231
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00819672	1.6100018103858231
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00819672	1.6100018103858231
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.00819672	1.6100018103858231
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000915751	0.17987204245876742
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000915751	0.17987204245876742
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000915751	0.17987204245876742
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000915751	0.17987204245876742
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.000915751	0.17987204245876742
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000915751	0.17987204245876742
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000915751	0.17987204245876742
SUPRABULBAR PARESIS, CONGENITAL	0.000915751	0.17987204245876742
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000915751	0.17987204245876742
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000915751	0.17987204245876742
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.000915751	0.17987204245876742
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.000915751	0.17987204245876742
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000915751	0.17987204245876742
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000915751	0.17987204245876742
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.000915751	0.17987204245876742
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000915751	0.17987204245876742
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.000915751	0.17987204245876742
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.000915751	0.17987204245876742
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000915751	0.17987204245876742
GAUCHER DISEASE, TYPE IIIC	0.000915751	0.17987204245876742
LISSENCEPHALY, X-LINKED, 2	0.000915751	0.17987204245876742
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.000915751	0.17987204245876742
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000915751	0.17987204245876742
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.000915751	0.17987204245876742
FLYNN-AIRD SYNDROME	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.000915751	0.17987204245876742
SMITH-KINGSMORE SYNDROME; SKS	0.000915751	0.17987204245876742
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.000915751	0.17987204245876742
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000915751	0.17987204245876742
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000915751	0.17987204245876742
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.000915751	0.17987204245876742
SHUKLA-VERNON SYNDROME; SHUVER	0.000915751	0.17987204245876742
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000915751	0.17987204245876742
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.000915751	0.17987204245876742
Myhre syndrome	0.000915751	0.17987204245876742
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000915751	0.17987204245876742
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.000915751	0.17987204245876742
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000915751	0.17987204245876742
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.000915751	0.17987204245876742
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000915751	0.17987204245876742
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000915751	0.17987204245876742
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000915751	0.17987204245876742
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.000915751	0.17987204245876742
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000915751	0.17987204245876742
MEND SYNDROME; MEND	0.000915751	0.17987204245876742
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000915751	0.17987204245876742
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000915751	0.17987204245876742
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.000915751	0.17987204245876742
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.000915751	0.17987204245876742
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000915751	0.17987204245876742
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000915751	0.17987204245876742
GLYCEROL KINASE DEFICIENCY; GKD	0.000915751	0.17987204245876742
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000915751	0.17987204245876742
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000915751	0.17987204245876742
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.000915751	0.17987204245876742
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000915751	0.17987204245876742
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.000915751	0.17987204245876742
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000915751	0.17987204245876742
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000915751	0.17987204245876742
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000915751	0.17987204245876742
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.000915751	0.17987204245876742
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.000915751	0.17987204245876742
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.000915751	0.17987204245876742
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.000915751	0.17987204245876742
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.000915751	0.17987204245876742
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000915751	0.17987204245876742
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.000915751	0.17987204245876742
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000915751	0.17987204245876742
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000915751	0.17987204245876742
MECKEL SYNDROME, TYPE 10; MKS10	0.000915751	0.17987204245876742
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000915751	0.17987204245876742
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.000915751	0.17987204245876742
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000915751	0.17987204245876742
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.000915751	0.17987204245876742
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000915751	0.17987204245876742
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.000915751	0.17987204245876742
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.000915751	0.17987204245876742
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.000915751	0.17987204245876742
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000915751	0.17987204245876742
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000915751	0.17987204245876742
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.000915751	0.17987204245876742
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000915751	0.17987204245876742
Angelman syndrome (Type 1)	0.000915751	0.17987204245876742
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000915751	0.17987204245876742
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.000915751	0.17987204245876742
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.000915751	0.17987204245876742
Pierpont syndrome	0.000915751	0.17987204245876742
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.000915751	0.17987204245876742
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000915751	0.17987204245876742
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000915751	0.17987204245876742
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000915751	0.17987204245876742
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.000915751	0.17987204245876742
#614483 PORENCEPHALY 2; POREN2	0.000915751	0.17987204245876742
NOONAN SYNDROME 7; NS7	0.000915751	0.17987204245876742
COFFIN-SIRIS SYNDROME 3; CSS3	0.000915751	0.17987204245876742
CORNELIA DE LANGE SYNDROME 1	0.000915751	0.17987204245876742
INFANTILE LIVER FAILURE SYNDROME 1	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.000915751	0.17987204245876742
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.000915751	0.17987204245876742
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000915751	0.17987204245876742
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.000915751	0.17987204245876742
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED 103	0.000915751	0.17987204245876742
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000915751	0.17987204245876742
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000915751	0.17987204245876742
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000915751	0.17987204245876742
KETOADIPICACIDURIA	0.000915751	0.17987204245876742
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000915751	0.17987204245876742
#602398 DESMOSTEROLOSIS	0.000915751	0.17987204245876742
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000915751	0.17987204245876742
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000915751	0.17987204245876742
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000915751	0.17987204245876742
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000915751	0.17987204245876742
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000915751	0.17987204245876742
THREONINEMIA	0.000915751	0.17987204245876742
CHROMOSOME 18Q DELETION SYNDROME	0.000915751	0.17987204245876742
GRISCELLI SYNDROME, TYPE 2; GS2	0.000915751	0.17987204245876742
METACHROMATIC LEUKODYSTROPHY	0.000915751	0.17987204245876742
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000915751	0.17987204245876742
OROFACIODIGITAL SYNDROME I; OFD1	0.000915751	0.17987204245876742
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000915751	0.17987204245876742
MAPLE SYRUP URINE DISEASE; MSUD	0.000915751	0.17987204245876742
LISSENCEPHALY 4	0.000915751	0.17987204245876742
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000915751	0.17987204245876742
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.000915751	0.17987204245876742
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.000915751	0.17987204245876742
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000915751	0.17987204245876742
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000915751	0.17987204245876742
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000915751	0.17987204245876742
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000915751	0.17987204245876742
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.000915751	0.17987204245876742
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.000915751	0.17987204245876742
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.000915751	0.17987204245876742
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.000915751	0.17987204245876742
ALZHEIMER DISEASE 3; AD	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000915751	0.17987204245876742
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.000915751	0.17987204245876742
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000915751	0.17987204245876742
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000915751	0.17987204245876742
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000915751	0.17987204245876742
HYPOMAGNESEMIA 2, RENAL	0.000915751	0.17987204245876742
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.000915751	0.17987204245876742
GLASS SYNDROME	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000915751	0.17987204245876742
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.000915751	0.17987204245876742
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.000915751	0.17987204245876742
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.000915751	0.17987204245876742
KNOBLOCH SYNDROME 1; KNO1	0.000915751	0.17987204245876742
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.000915751	0.17987204245876742
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.000915751	0.17987204245876742
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000915751	0.17987204245876742
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000915751	0.17987204245876742
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.000915751	0.17987204245876742
COFFIN-SIRIS SYNDROME 5	0.000915751	0.17987204245876742
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000915751	0.17987204245876742
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000915751	0.17987204245876742
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.000915751	0.17987204245876742
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000915751	0.17987204245876742
MEGALENCEPHALY WITH DYSMYELINATION	0.000915751	0.17987204245876742
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000915751	0.17987204245876742
DIAMINOPENTANURIA	0.000915751	0.17987204245876742
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000915751	0.17987204245876742
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000915751	0.17987204245876742
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.000915751	0.17987204245876742
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.000915751	0.17987204245876742
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000915751	0.17987204245876742
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000915751	0.17987204245876742
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.000915751	0.17987204245876742
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000915751	0.17987204245876742
ADAMS-OLIVER SYNDROME 5; AOS5	0.000915751	0.17987204245876742
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000915751	0.17987204245876742
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.000915751	0.17987204245876742
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.000915751	0.17987204245876742
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000915751	0.17987204245876742
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.000915751	0.17987204245876742
OCULODENTODIGITAL DYSPLASIA; ODDD	0.000915751	0.17987204245876742
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.000915751	0.17987204245876742
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.000915751	0.17987204245876742
PYRUVATE CARBOXYLASE DEFICIENCY	0.000915751	0.17987204245876742
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED 9	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.000915751	0.17987204245876742
CHROMOSOME 16p13.2 DELETION SYNDROME	0.000915751	0.17987204245876742
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.000915751	0.17987204245876742
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000915751	0.17987204245876742
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000915751	0.17987204245876742
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.000915751	0.17987204245876742
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000915751	0.17987204245876742
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000915751	0.17987204245876742
Pontine tegmental cap dysplasia	0.000915751	0.17987204245876742
GLUTARIC ACIDEMIA I; GA1	0.000915751	0.17987204245876742
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.000915751	0.17987204245876742
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.000915751	0.17987204245876742
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000915751	0.17987204245876742
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000915751	0.17987204245876742
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000915751	0.17987204245876742
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.000915751	0.17987204245876742
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000915751	0.17987204245876742
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000915751	0.17987204245876742
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.000915751	0.17987204245876742
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.000915751	0.17987204245876742
LUSCAN-LUMISH SYNDROME; LLS	0.000915751	0.17987204245876742
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000915751	0.17987204245876742
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000915751	0.17987204245876742
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.000915751	0.17987204245876742
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.000915751	0.17987204245876742
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	0.000915751	0.17987204245876742
DARIER-WHITE DISEASE; DAR	0.000915751	0.17987204245876742
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.000915751	0.17987204245876742
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000915751	0.17987204245876742
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000915751	0.17987204245876742
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.000915751	0.17987204245876742
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000915751	0.17987204245876742
CYCLIC VOMITING SYNDROME	0.000915751	0.17987204245876742
SJOGREN-LARSSON SYNDROME; SLS	0.000915751	0.17987204245876742
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.000915751	0.17987204245876742
SNEDDON SYNDROME	0.000915751	0.17987204245876742
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000915751	0.17987204245876742
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.000915751	0.17987204245876742
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.000915751	0.17987204245876742
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.000915751	0.17987204245876742
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000915751	0.17987204245876742
KEUTEL SYNDROME; KTLS	0.000915751	0.17987204245876742
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000915751	0.17987204245876742
CHROMOSOME 2q37 DELETION SYNDROME	0.000915751	0.17987204245876742
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000915751	0.17987204245876742
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000915751	0.17987204245876742
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000915751	0.17987204245876742
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.000915751	0.17987204245876742
CORNELIA DE LANGE SYNDROME 3	0.000915751	0.17987204245876742
TENORIO SYNDROME; TNORS	0.000915751	0.17987204245876742
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.000915751	0.17987204245876742
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.000915751	0.17987204245876742
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.000915751	0.17987204245876742
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.000915751	0.17987204245876742
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000915751	0.17987204245876742
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.000915751	0.17987204245876742
NIEMANN-PICK DISEASE, TYPE C2	0.000915751	0.17987204245876742
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.000915751	0.17987204245876742
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.000915751	0.17987204245876742
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000915751	0.17987204245876742
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000915751	0.17987204245876742
CODAS SYNDROME	0.000915751	0.17987204245876742
KEARNS-SAYRE SYNDROME; KSS	0.000915751	0.17987204245876742
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.000915751	0.17987204245876742
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000915751	0.17987204245876742
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000915751	0.17987204245876742
Adrenoleukodystrophy	0.000915751	0.17987204245876742
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.000915751	0.17987204245876742
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000915751	0.17987204245876742
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000915751	0.17987204245876742
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000915751	0.17987204245876742
HYPOPARATHYROIDISM, X-LINKED	0.000915751	0.17987204245876742
ATKIN-FLAITZ SYNDROME	0.000915751	0.17987204245876742
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.000915751	0.17987204245876742
CHROMOSOME 16p13.3 DELETION SYNDROME	0.000915751	0.17987204245876742
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.000915751	0.17987204245876742
WITTEVEEN-KOLK SYNDROME	0.000915751	0.17987204245876742
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000915751	0.17987204245876742
FRAGILE X MENTAL RETARDATION SYNDROME	0.000915751	0.17987204245876742
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000915751	0.17987204245876742
COWDEN SYNDROME 6; CWS6	0.000915751	0.17987204245876742
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.000915751	0.17987204245876742
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.000915751	0.17987204245876742
LISSENCEPHALY 3; LIS3	0.000915751	0.17987204245876742
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.000915751	0.17987204245876742
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000915751	0.17987204245876742
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.000915751	0.17987204245876742
PALLISTER-KILLIAN SYNDROME	0.000915751	0.17987204245876742
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000915751	0.17987204245876742
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000915751	0.17987204245876742
CHROMOSOME 10Q26 DELETION SYNDROME	0.000915751	0.17987204245876742
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.000915751	0.17987204245876742
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000915751	0.17987204245876742
XYLOSIDASE DEFICIENCY	0.000915751	0.17987204245876742
#604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE	0.000915751	0.17987204245876742
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.000915751	0.17987204245876742
SECKEL SYNDROME 7; SCKL7	0.000915751	0.17987204245876742
KLEEFSTRA SYNDROME	0.000915751	0.17987204245876742
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000915751	0.17987204245876742
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED 88	0.000915751	0.17987204245876742
GAUCHER DISEASE, TYPE II	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000915751	0.17987204245876742
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.000915751	0.17987204245876742
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.000915751	0.17987204245876742
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.000915751	0.17987204245876742
IMMUNODEFICIENCY 49; IMD49	0.000915751	0.17987204245876742
HYPER-BETA-ALANINEMIA	0.000915751	0.17987204245876742
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000915751	0.17987204245876742
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.000915751	0.17987204245876742
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000915751	0.17987204245876742
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000915751	0.17987204245876742
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.000915751	0.17987204245876742
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.000915751	0.17987204245876742
Angelman syndrome (Type 2)	0.000915751	0.17987204245876742
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.000915751	0.17987204245876742
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000915751	0.17987204245876742
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.000915751	0.17987204245876742
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000915751	0.17987204245876742
OHDO SYNDROME	0.000915751	0.17987204245876742
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000915751	0.17987204245876742
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.000915751	0.17987204245876742
LISSENCEPHALY 1; LIS1	0.000915751	0.17987204245876742
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000915751	0.17987204245876742
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000915751	0.17987204245876742
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.000915751	0.17987204245876742
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.000915751	0.17987204245876742
HUNTINGTON DISEASE; HD	0.000915751	0.17987204245876742
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.000915751	0.17987204245876742
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000915751	0.17987204245876742
NEUROFIBROMATOSIS, TYPE II	0.000915751	0.17987204245876742
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000915751	0.17987204245876742
ADENYLOSUCCINASE DEFICIENCY	0.000915751	0.17987204245876742
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.000915751	0.17987204245876742
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.000915751	0.17987204245876742
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.000915751	0.17987204245876742
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.000915751	0.17987204245876742
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000915751	0.17987204245876742
COFFIN-SIRIS SYNDROME 2; CSS2	0.000915751	0.17987204245876742
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.000915751	0.17987204245876742
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.000915751	0.17987204245876742
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.000915751	0.17987204245876742
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000915751	0.17987204245876742
PAPILLORENAL SYNDROME	0.000915751	0.17987204245876742
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.000915751	0.17987204245876742
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000915751	0.17987204245876742
PELIZAEUS-MERZBACHER DISEASE	0.000915751	0.17987204245876742
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000915751	0.17987204245876742
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.000915751	0.17987204245876742
ADAMS-OLIVER SYNDROME 1; AOS1	0.000915751	0.17987204245876742
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000915751	0.17987204245876742
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.000915751	0.17987204245876742
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.000915751	0.17987204245876742
LISSENCEPHALY 8; LIS8	0.000915751	0.17987204245876742
RAYNAUD-CLAES SYNDROME; MRXSRC	0.000915751	0.17987204245876742
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.000915751	0.17987204245876742
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.000915751	0.17987204245876742
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000915751	0.17987204245876742
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000915751	0.17987204245876742
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000915751	0.17987204245876742
NEURAMINIDASE DEFICIENCY	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000915751	0.17987204245876742
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000915751	0.17987204245876742
#615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR ;;PMGR	0.000915751	0.17987204245876742
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000915751	0.17987204245876742
HYPEREKPLEXIA 4; HKPX4	0.000915751	0.17987204245876742
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.000915751	0.17987204245876742
BARAITSER-WINTER SYNDROME 1; BRWS1	0.000915751	0.17987204245876742
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.000915751	0.17987204245876742
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.000915751	0.17987204245876742
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.000915751	0.17987204245876742
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000915751	0.17987204245876742
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000915751	0.17987204245876742
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000915751	0.17987204245876742
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000915751	0.17987204245876742
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED 98; MRX98	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000915751	0.17987204245876742
EPILEPSY, READING	0.000915751	0.17987204245876742
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.000915751	0.17987204245876742
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000915751	0.17987204245876742
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.000915751	0.17987204245876742
BAND HETEROTOPIA; BH	0.000915751	0.17987204245876742
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000915751	0.17987204245876742
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000915751	0.17987204245876742
COFFIN-SIRIS SYNDROME 8; CSS8	0.000915751	0.17987204245876742
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000915751	0.17987204245876742
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.000915751	0.17987204245876742
INFANTILE LIVER FAILURE SYNDROME 2	0.000915751	0.17987204245876742
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000915751	0.17987204245876742
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000915751	0.17987204245876742
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.000915751	0.17987204245876742
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.000915751	0.17987204245876742
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000915751	0.17987204245876742
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000915751	0.17987204245876742
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.000915751	0.17987204245876742
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.000915751	0.17987204245876742
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.000915751	0.17987204245876742
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000915751	0.17987204245876742
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000915751	0.17987204245876742
AUTISM	0.000915751	0.17987204245876742
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.000915751	0.17987204245876742
ZTTK SYNDROME; ZTTKS	0.000915751	0.17987204245876742
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED 90	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.000915751	0.17987204245876742
#300867 KABUKI SYNDROME 2; KABUK2	0.000915751	0.17987204245876742
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000915751	0.17987204245876742
N-ACETYLASPARTATE DEFICIENCY; NACED	0.000915751	0.17987204245876742
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000915751	0.17987204245876742
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000915751	0.17987204245876742
PETTIGREW SYNDROME	0.000915751	0.17987204245876742
HYPERLEUCINE-ISOLEUCINEMIA	0.000915751	0.17987204245876742
JABERI-ELAHI SYNDROME; JABELS	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.000915751	0.17987204245876742
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.000915751	0.17987204245876742
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000915751	0.17987204245876742
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.000915751	0.17987204245876742
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.000915751	0.17987204245876742
ICHTHYOSIS AND MALE HYPOGONADISM	0.000915751	0.17987204245876742
PRADER-WILLI SYNDROME; PWS	0.000915751	0.17987204245876742
IMMUNODEFICIENCY 47	0.000915751	0.17987204245876742
Muenke syndrome	0.000915751	0.17987204245876742
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.000915751	0.17987204245876742
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000915751	0.17987204245876742
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000915751	0.17987204245876742
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000915751	0.17987204245876742
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000915751	0.17987204245876742
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.000915751	0.17987204245876742
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000915751	0.17987204245876742
COHEN SYNDROME	0.000915751	0.17987204245876742
SALLA DISEASE	0.000915751	0.17987204245876742
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.000915751	0.17987204245876742
MACDERMOT-WINTER SYNDROME	0.000915751	0.17987204245876742
HHHH SYNDROME	0.000915751	0.17987204245876742
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.000915751	0.17987204245876742
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.000915751	0.17987204245876742
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000915751	0.17987204245876742
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000915751	0.17987204245876742
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000915751	0.17987204245876742
SECKEL SYNDROME 1; SCKL1	0.000915751	0.17987204245876742
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000915751	0.17987204245876742
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000915751	0.17987204245876742
SULFOCYSTEINURIA	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000915751	0.17987204245876742
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.000915751	0.17987204245876742
COFFIN-LOWRY SYNDROME; CLS	0.000915751	0.17987204245876742
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000915751	0.17987204245876742
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000915751	0.17987204245876742
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000915751	0.17987204245876742
COCKAYNE SYNDROME A; CSA	0.000915751	0.17987204245876742
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.000915751	0.17987204245876742
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000915751	0.17987204245876742
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.000915751	0.17987204245876742
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.000915751	0.17987204245876742
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000915751	0.17987204245876742
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000915751	0.17987204245876742
FRYNS SYNDROME; FRNS	0.000915751	0.17987204245876742
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.000915751	0.17987204245876742
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.000915751	0.17987204245876742
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.000915751	0.17987204245876742
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000915751	0.17987204245876742
224250 DYSMYELINATION WITH JAUNDICE	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED 82	0.000915751	0.17987204245876742
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.000915751	0.17987204245876742
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.000915751	0.17987204245876742
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000915751	0.17987204245876742
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000915751	0.17987204245876742
WIEACKER-WOLFF SYNDROME	0.000915751	0.17987204245876742
RETINITIS PIGMENTOSA 59; RP59	0.000915751	0.17987204245876742
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.000915751	0.17987204245876742
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.000915751	0.17987204245876742
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.000915751	0.17987204245876742
PACHYGYRIA, FRONTOTEMPORAL	0.000915751	0.17987204245876742
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000915751	0.17987204245876742
ARGININOSUCCINIC ACIDURIA	0.000915751	0.17987204245876742
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.000915751	0.17987204245876742
INCONTINENTIA PIGMENTI; IP	0.000915751	0.17987204245876742
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.000915751	0.17987204245876742
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000915751	0.17987204245876742
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000915751	0.17987204245876742
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.000915751	0.17987204245876742
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000915751	0.17987204245876742
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000915751	0.17987204245876742
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000915751	0.17987204245876742
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.000915751	0.17987204245876742
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000915751	0.17987204245876742
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000915751	0.17987204245876742
MICROPHTHALMIA, SYNDROMIC 1	0.000915751	0.17987204245876742
EPISODIC ATAXIA, TYPE 6	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.000915751	0.17987204245876742
AICARDI-GOUTIERES SYNDROME 7	0.000915751	0.17987204245876742
ELEJALDE DISEASE	0.000915751	0.17987204245876742
HEART AND BRAIN MALFORMATION SYNDROME	0.000915751	0.17987204245876742
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000915751	0.17987204245876742
TAY-SACHS DISEASE; TSD	0.000915751	0.17987204245876742
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000915751	0.17987204245876742
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000915751	0.17987204245876742
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.000915751	0.17987204245876742
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000915751	0.17987204245876742
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.000915751	0.17987204245876742
PEHO SYNDROME; PEHO	0.000915751	0.17987204245876742
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000915751	0.17987204245876742
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.000915751	0.17987204245876742
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.000915751	0.17987204245876742
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED 14	0.000915751	0.17987204245876742
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000915751	0.17987204245876742
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000915751	0.17987204245876742
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000915751	0.17987204245876742
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000915751	0.17987204245876742
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.000915751	0.17987204245876742
KABUKI SYNDROME 1	0.000915751	0.17987204245876742
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000915751	0.17987204245876742
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000915751	0.17987204245876742
POTOCKI-LUPSKI SYNDROME	0.000915751	0.17987204245876742
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.000915751	0.17987204245876742
GLYCINE ENCEPHALOPATHY; GCE	0.000915751	0.17987204245876742
RAMON SYNDROME	0.000915751	0.17987204245876742
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.000915751	0.17987204245876742
PERRAULT SYNDROME 3	0.000915751	0.17987204245876742
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000915751	0.17987204245876742
2q33.1 deletion syndrome	0.000915751	0.17987204245876742
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.000915751	0.17987204245876742
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000915751	0.17987204245876742
COFFIN-SIRIS SYNDROME 1; CSS1	0.000915751	0.17987204245876742
RECOMBINANT CHROMOSOME 8 SYNDROME	0.000915751	0.17987204245876742
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000915751	0.17987204245876742
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000915751	0.17987204245876742
Cerebral creatine deficiency syndrome 2	0.000915751	0.17987204245876742
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.000915751	0.17987204245876742
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.000915751	0.17987204245876742
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000915751	0.17987204245876742
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.000915751	0.17987204245876742
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000915751	0.17987204245876742
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.000915751	0.17987204245876742
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.000915751	0.17987204245876742
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.000915751	0.17987204245876742
Fabry disease	0.000915751	0.17987204245876742
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.000915751	0.17987204245876742
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.000915751	0.17987204245876742
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000915751	0.17987204245876742
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.000915751	0.17987204245876742
HYPERPROLINEMIA, TYPE II	0.000915751	0.17987204245876742
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000915751	0.17987204245876742
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000915751	0.17987204245876742
NEUROFIBROMATOSIS, TYPE I	0.000915751	0.17987204245876742
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.000915751	0.17987204245876742
PHELAN-MCDERMID SYNDROME; PHMDS	0.000915751	0.17987204245876742
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.000915751	0.17987204245876742
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.000915751	0.17987204245876742
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.000915751	0.17987204245876742
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000915751	0.17987204245876742
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000915751	0.17987204245876742
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000915751	0.17987204245876742
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000915751	0.17987204245876742
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000915751	0.17987204245876742
#613707 LEOPARD SYNDROME 3; LPRD3	0.000915751	0.17987204245876742
CRANIOSYNOSTOSIS 2	0.000915751	0.17987204245876742
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.000915751	0.17987204245876742
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000915751	0.17987204245876742
Helsmoortel-van der Aa syndrome	0.000915751	0.17987204245876742
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000915751	0.17987204245876742
HYPOADRENOCORTICISM, FAMILIAL	0.000915751	0.17987204245876742
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.000915751	0.17987204245876742
ZIMMERMANN-LABAND SYNDROME 1	0.000915751	0.17987204245876742
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.000915751	0.17987204245876742
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.000915751	0.17987204245876742
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000915751	0.17987204245876742
KRABBE DISEASE	0.000915751	0.17987204245876742
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000915751	0.17987204245876742
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.000915751	0.17987204245876742
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000915751	0.17987204245876742
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000915751	0.17987204245876742
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.000915751	0.17987204245876742
ADAMS-OLIVER SYNDROME 2; AOS2	0.000915751	0.17987204245876742
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000915751	0.17987204245876742
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000915751	0.17987204245876742
BOHRING-OPITZ SYNDROME	0.000915751	0.17987204245876742
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.000915751	0.17987204245876742
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000915751	0.17987204245876742
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.000915751	0.17987204245876742
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000915751	0.17987204245876742
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000915751	0.17987204245876742
XQ25 DUPLICATION SYNDROME	0.000915751	0.17987204245876742
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000915751	0.17987204245876742
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.000915751	0.17987204245876742
POTOCKI-SHAFFER SYNDROME	0.000915751	0.17987204245876742
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.000915751	0.17987204245876742
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000915751	0.17987204245876742
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000915751	0.17987204245876742
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000915751	0.17987204245876742
EPILEPSY, BENIGN OCCIPITAL	0.000915751	0.17987204245876742
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000915751	0.17987204245876742
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000915751	0.17987204245876742
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.000915751	0.17987204245876742
FOLATE MALABSORPTION, HEREDITARY	0.000915751	0.17987204245876742
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000915751	0.17987204245876742
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.000915751	0.17987204245876742
WAISMAN SYNDROME; WSMN	0.000915751	0.17987204245876742
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000915751	0.17987204245876742
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000915751	0.17987204245876742
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.000915751	0.17987204245876742
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.000915751	0.17987204245876742
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.000915751	0.17987204245876742
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.000915751	0.17987204245876742
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.000915751	0.17987204245876742
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.000915751	0.17987204245876742
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000915751	0.17987204245876742
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000915751	0.17987204245876742
ACROCALLOSAL SYNDROME; ACLS	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.000915751	0.17987204245876742
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.000915751	0.17987204245876742
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000915751	0.17987204245876742
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.000915751	0.17987204245876742
HYPERPROLINEMIA, TYPE I	0.000915751	0.17987204245876742
COWDEN SYNDROME 5; CWS5	0.000915751	0.17987204245876742
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000915751	0.17987204245876742
GRISCELLI SYNDROME, TYPE 1	0.000915751	0.17987204245876742
GLUTAMINE DEFICIENCY, CONGENITAL	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000915751	0.17987204245876742
CROUZON SYNDROME	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000915751	0.17987204245876742
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.000915751	0.17987204245876742
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000915751	0.17987204245876742
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000915751	0.17987204245876742
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.000915751	0.17987204245876742
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.000915751	0.17987204245876742
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000915751	0.17987204245876742
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.000915751	0.17987204245876742
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000915751	0.17987204245876742
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000915751	0.17987204245876742
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000915751	0.17987204245876742
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000915751	0.17987204245876742
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.000915751	0.17987204245876742
AL KAISSI SYNDROME; ALKAS	0.000915751	0.17987204245876742
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000915751	0.17987204245876742
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.000915751	0.17987204245876742
AYME-GRIPP SYNDROME; AYGRP	0.000915751	0.17987204245876742
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.000915751	0.17987204245876742
HYPOPHOSPHATASIA, CHILDHOOD	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED 104; MRX104	0.000915751	0.17987204245876742
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.000915751	0.17987204245876742
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.000915751	0.17987204245876742
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.000915751	0.17987204245876742
COACH SYNDROME	0.000915751	0.17987204245876742
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000915751	0.17987204245876742
ALEXANDER DISEASE	0.000915751	0.17987204245876742
C SYNDROME	0.000915751	0.17987204245876742
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.000915751	0.17987204245876742
OCULOCEREBROCUTANEOUS SYNDROME	0.000915751	0.17987204245876742
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000915751	0.17987204245876742
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000915751	0.17987204245876742
LATHOSTEROLOSIS	0.000915751	0.17987204245876742
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000915751	0.17987204245876742
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000915751	0.17987204245876742
15q13.3 microdeletion syndrome	0.000915751	0.17987204245876742
HYPERLYSINEMIA, TYPE I	0.000915751	0.17987204245876742
EPILEPSY-TELANGIECTASIA	0.000915751	0.17987204245876742
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000915751	0.17987204245876742
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000915751	0.17987204245876742
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000915751	0.17987204245876742
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.000915751	0.17987204245876742
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000915751	0.17987204245876742
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.000915751	0.17987204245876742
MEHMO SYNDROME; MEHMO	0.000915751	0.17987204245876742
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000915751	0.17987204245876742
1p36 microdeletion syndrome	0.000915751	0.17987204245876742
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000915751	0.17987204245876742
PREECLAMPSIA/ECLAMPSIA 1	0.000915751	0.17987204245876742
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.000915751	0.17987204245876742
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.000915751	0.17987204245876742
PSEUDO-TORCH SYNDROME 2	0.000915751	0.17987204245876742
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.000915751	0.17987204245876742
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.000915751	0.17987204245876742
ACTH DEFICIENCY, ISOLATED; IAD	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000915751	0.17987204245876742
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000915751	0.17987204245876742
PHACE ASSOCIATION	0.000915751	0.17987204245876742
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED 72	0.000915751	0.17987204245876742
GURRIERI SYNDROME	0.000915751	0.17987204245876742
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.000915751	0.17987204245876742
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000915751	0.17987204245876742
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000915751	0.17987204245876742
ASPARTYLGLUCOSAMINURIA; AGU	0.000915751	0.17987204245876742
HARTNUP DISORDER	0.000915751	0.17987204245876742
PERRAULT SYNDROME 5; PRLTS5	0.000915751	0.17987204245876742
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000915751	0.17987204245876742
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000915751	0.17987204245876742
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000915751	0.17987204245876742
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.000915751	0.17987204245876742
BRANCHIOOCULOFACIAL SYNDROME	0.000915751	0.17987204245876742
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.000915751	0.17987204245876742
STURGE-WEBER SYNDROME	0.000915751	0.17987204245876742
FOUNTAIN SYNDROME	0.000915751	0.17987204245876742
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.000915751	0.17987204245876742
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.000915751	0.17987204245876742
TIMOTHY SYNDROME; TS	0.000915751	0.17987204245876742
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000915751	0.17987204245876742
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.000915751	0.17987204245876742
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000915751	0.17987204245876742
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000915751	0.17987204245876742
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.000915751	0.17987204245876742
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.000915751	0.17987204245876742
CATEL-MANZKE SYNDROME; CATMANS	0.000915751	0.17987204245876742
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.000915751	0.17987204245876742
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.000915751	0.17987204245876742
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.000915751	0.17987204245876742
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000915751	0.17987204245876742
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.000915751	0.17987204245876742
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000915751	0.17987204245876742
GRACILE BONE DYSPLASIA; GCLEB	0.000915751	0.17987204245876742
TEMTAMY SYNDROME; TEMTYS	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000915751	0.17987204245876742
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.000915751	0.17987204245876742
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000915751	0.17987204245876742
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000915751	0.17987204245876742
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.000915751	0.17987204245876742
MENTAL RETARDATION, FRA12A TYPE	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.000915751	0.17987204245876742
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.000915751	0.17987204245876742
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000915751	0.17987204245876742
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000915751	0.17987204245876742
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	0.000915751	0.17987204245876742
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.000915751	0.17987204245876742
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000915751	0.17987204245876742
GABA-TRANSAMINASE DEFICIENCY	0.000915751	0.17987204245876742
CHROMOSOME 1p35 DELETION SYNDROME	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000915751	0.17987204245876742
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.000915751	0.17987204245876742
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000915751	0.17987204245876742
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000915751	0.17987204245876742
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.000915751	0.17987204245876742
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000915751	0.17987204245876742
GAPO SYNDROME; GAPOS	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.000915751	0.17987204245876742
#605375 EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3	0.000915751	0.17987204245876742
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000915751	0.17987204245876742
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000915751	0.17987204245876742
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.000915751	0.17987204245876742
JOUBERT SYNDROME 30; JBTS30	0.000915751	0.17987204245876742
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000915751	0.17987204245876742
PAPILLOMA OF CHOROID PLEXUS	0.000915751	0.17987204245876742
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000915751	0.17987204245876742
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.000915751	0.17987204245876742
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.000915751	0.17987204245876742
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000915751	0.17987204245876742
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.000915751	0.17987204245876742
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000915751	0.17987204245876742
METHYLMALONIC ACIDURIA, CBLA TYPE	0.000915751	0.17987204245876742
ZUNICH NEUROECTODERMAL SYNDROME	0.000915751	0.17987204245876742
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.000915751	0.17987204245876742
CEREBELLOPARENCHYMAL DISORDER II	0.000915751	0.17987204245876742
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000915751	0.17987204245876742
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000915751	0.17987204245876742
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000915751	0.17987204245876742
PETERS-PLUS SYNDROME; PTRPLS	0.000915751	0.17987204245876742
CITRULLINEMIA, CLASSIC	0.000915751	0.17987204245876742
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY	0.000915751	0.17987204245876742
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000915751	0.17987204245876742
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.000915751	0.17987204245876742
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000915751	0.17987204245876742
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000915751	0.17987204245876742
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000915751	0.17987204245876742
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000915751	0.17987204245876742
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.000915751	0.17987204245876742
MARDEN-WALKER SYNDROME	0.000915751	0.17987204245876742
KLEEFSTRA SYNDROME 2; KLEFS2	0.000915751	0.17987204245876742
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000915751	0.17987204245876742
WEAVER SYNDROME	0.000915751	0.17987204245876742
DYSOSTEOSCLEROSIS	0.000915751	0.17987204245876742
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.000915751	0.17987204245876742
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000915751	0.17987204245876742
MIRAGE SYNDROME; MIRAGE	0.000915751	0.17987204245876742
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000915751	0.17987204245876742
SCHINDLER DISEASE, TYPE I	0.000915751	0.17987204245876742
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000915751	0.17987204245876742
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000915751	0.17987204245876742
LANDAU-KLEFFNER SYNDROME	0.000915751	0.17987204245876742
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000915751	0.17987204245876742
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000915751	0.17987204245876742
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.000915751	0.17987204245876742
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000915751	0.17987204245876742
KOOLEN-DE VRIES SYNDROME; KDVS	0.000915751	0.17987204245876742
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.000915751	0.17987204245876742
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.000915751	0.17987204245876742
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.000915751	0.17987204245876742
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000915751	0.17987204245876742
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.000915751	0.17987204245876742
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.000915751	0.17987204245876742
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000915751	0.17987204245876742
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000915751	0.17987204245876742
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000915751	0.17987204245876742
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000915751	0.17987204245876742
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000915751	0.17987204245876742
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000915751	0.17987204245876742
KBG SYNDROME	0.000915751	0.17987204245876742
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.000915751	0.17987204245876742
VISCERAL STEATOSIS, CONGENITAL	0.000915751	0.17987204245876742
CHROMOSOME 5Q12 DELETION SYNDROME	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000915751	0.17987204245876742
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000915751	0.17987204245876742
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000915751	0.17987204245876742
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.000915751	0.17987204245876742
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.000915751	0.17987204245876742
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.000915751	0.17987204245876742
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000915751	0.17987204245876742
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000915751	0.17987204245876742
MENKES DISEASE	0.000915751	0.17987204245876742
DIGEORGE SYNDROME; DGS	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.000915751	0.17987204245876742
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.000915751	0.17987204245876742
RETINAL DEGENERATION AND EPILEPSY	0.000915751	0.17987204245876742
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.000915751	0.17987204245876742
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.000915751	0.17987204245876742
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.000915751	0.17987204245876742
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000915751	0.17987204245876742
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.000915751	0.17987204245876742
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.000915751	0.17987204245876742
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.000915751	0.17987204245876742
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000915751	0.17987204245876742
COFFIN-SIRIS SYNDROME 4; CSS4	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.000915751	0.17987204245876742
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000915751	0.17987204245876742
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.000915751	0.17987204245876742
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000915751	0.17987204245876742
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000915751	0.17987204245876742
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000915751	0.17987204245876742
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.000915751	0.17987204245876742
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000915751	0.17987204245876742
CROME SYNDROME	0.000915751	0.17987204245876742
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.000915751	0.17987204245876742
PHENYLKETONURIA	0.000915751	0.17987204245876742
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000915751	0.17987204245876742
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000915751	0.17987204245876742
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.000915751	0.17987204245876742
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000915751	0.17987204245876742
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.000915751	0.17987204245876742
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.000915751	0.17987204245876742
LEIGH SYNDROME; LS	0.000915751	0.17987204245876742
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000915751	0.17987204245876742
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000915751	0.17987204245876742
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.000915751	0.17987204245876742
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000915751	0.17987204245876742
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.000915751	0.17987204245876742
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.000915751	0.17987204245876742
LISSENCEPHALY 5; LIS5	0.000915751	0.17987204245876742
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000915751	0.17987204245876742
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.000915751	0.17987204245876742
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000915751	0.17987204245876742
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.000915751	0.17987204245876742
PARIETAL FORAMINA	0.000915751	0.17987204245876742
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000915751	0.17987204245876742
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.000915751	0.17987204245876742
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.000915751	0.17987204245876742
KUFOR-RAKEB SYNDROME	0.000915751	0.17987204245876742
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.000915751	0.17987204245876742
THYROCEREBRORETINAL SYNDROME	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED 100	0.000915751	0.17987204245876742
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000915751	0.17987204245876742
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000915751	0.17987204245876742
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.000915751	0.17987204245876742
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000915751	0.17987204245876742
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.000915751	0.17987204245876742
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.000915751	0.17987204245876742
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000915751	0.17987204245876742
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000915751	0.17987204245876742
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.000915751	0.17987204245876742
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.000915751	0.17987204245876742
RENPENNING SYNDROME 1; RENS1	0.000915751	0.17987204245876742
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000915751	0.17987204245876742
WARBURG MICRO SYNDROME 3; WARBM3	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED 1	0.000915751	0.17987204245876742
SHASHI-PENA SYNDROME; SHAPNS	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000915751	0.17987204245876742
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000915751	0.17987204245876742
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000915751	0.17987204245876742
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000915751	0.17987204245876742
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.000915751	0.17987204245876742
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000915751	0.17987204245876742
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.000915751	0.17987204245876742
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.000915751	0.17987204245876742
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000915751	0.17987204245876742
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.000915751	0.17987204245876742
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.000915751	0.17987204245876742
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.000915751	0.17987204245876742
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000915751	0.17987204245876742
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.000915751	0.17987204245876742
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.000915751	0.17987204245876742
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000915751	0.17987204245876742
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED 102	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.000915751	0.17987204245876742
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000915751	0.17987204245876742
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000915751	0.17987204245876742
Wolf-Hirschhorn Syndrome	0.000915751	0.17987204245876742
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.000915751	0.17987204245876742
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000915751	0.17987204245876742
FILIPPI SYNDROME; FLPIS	0.000915751	0.17987204245876742
KIFAFA SEIZURE DISORDER	0.000915751	0.17987204245876742
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.000915751	0.17987204245876742
IMMUNODEFICIENCY 37; IMD37	0.000915751	0.17987204245876742
CLARK-BARAITSER SYNDROME	0.000915751	0.17987204245876742
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000915751	0.17987204245876742
OCULOECTODERMAL SYNDROME; OES	0.000915751	0.17987204245876742
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.000915751	0.17987204245876742
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.000915751	0.17987204245876742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.000915751	0.17987204245876742
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.000915751	0.17987204245876742
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000915751	0.17987204245876742
SUDDEN CARDIAC FAILURE, INFANTILE	0.000915751	0.17987204245876742
#202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE	0.000915751	0.17987204245876742
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000915751	0.17987204245876742
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000915751	0.17987204245876742
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000915751	0.17987204245876742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000915751	0.17987204245876742
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.000915751	0.17987204245876742
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.000915751	0.17987204245876742
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.000915751	0.17987204245876742
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000915751	0.17987204245876742
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.000915751	0.17987204245876742
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.000915751	0.17987204245876742
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000915751	0.17987204245876742
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.000915751	0.17987204245876742
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000915751	0.17987204245876742
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000915751	0.17987204245876742
